News

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...
The drug comes in two forms: a disposable, prefilled FlexTouch injection ... 200 units of insulin degludec per 1 mL of solution Vial for use with syringes: This form of Tresiba contains 10 mL ...
27 patients started subcutaneous immunoglobulin with prefilled syringes administered via manual push. The other 9 patients had the therapy administered via a pump. However, during the study, 78% of ...
She noted that the WHO pre-qualification would allow AFRI Medical to export high-quality syringes globally, significantly enhancing Nigeria’s presence in the global medical device market.
The available dosages include 45 mg/0.5 mL prefilled syringe, 90 mg/mL prefilled syringe, 45 mg/0.5 mL vial, and 130 mg/26 mL vial. The US Food and Drug Administration (FDA) approved Yesintek in ...
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) in all presentations matching the reference product, effective as of ...
3D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision ...
Zepbound comes as a liquid solution in prefilled, disposable injection pens. It also comes in a vial to be used with a needle and syringe. The drug is given as an injection under your skin.
In type 1 diabetes ... and gauge for various sizes of needles and syringes. Barrel size (syringe fluid volume) Insulin units Needle length Needle gauge 0.3 mL 30 units of insulin 3/16 inch ...
SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device conferences, the 2022 ...
The pre-filled syringes industry is growing at an exponential rate. With increasing demand for self-administration, a rise in biologics, large-volume delivery and the delayed EU MDR at the ...